TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 3 | -2 | -5 | -12 | -15 | -2 | 26 | -2 |
| S | %wins | 67 | 67 | 100 | 100 | 67 | 33 | 72 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/09 18:16 | 12/16/09 | ACHN | Achillion Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Moorin Jay | NJ | T | S.dm | -1,964 | 3.49 | 2 | -563 | -17 | 2,664 | I | -28 | 254 | 169 | 84 | 120 | 86 | 59 | 67 | 3 | 2 | -16 | -14 | -29 | -7 | ||
10/13/09 17:21 | 10/9/09 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moorin Jay | NJ | T | S.dm | -4,105 | 2.31 | 4 | -1,779 | -20 | 7,126 | I | -10 | 341 | 283 | 0 | 6 | -2 | 4 | -16 | -1 | -1 | -9 | -9 | 48 | 63 | |
8/13/09 15:15 | 8/11/09 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moorin Jay | NJ | T | S.d | -3,201 | 3.58 | 7 | -894 | -9 | 8,905 | I | 39 | 157 | 370 | 211 | 35 | 5 | 19 | 13 | -9 | -15 | -11 | -22 | -26 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |